SCHEMBL4197047

SCHEMBL4197047

COc1cc(CC#N)ccc1OCC1CCN(C(=O)OCC(C)C)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 1/20 0.41
LMNA P02545 1/20 0.40
BRD4 O60885 1/20 0.40
MGLL Q99685 1/20 0.40
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
PTGDR2 Q9Y5Y4 1/20 0.39
ALDH1A1 P00352 2/20 0.39
ATM Q13315 1/20 0.39
PDE4B Q07343 2/20 0.39
PDE4A P27815 1/20 0.39
PDE4C Q08493 1/20 0.39
PDE4D Q08499 1/20 0.39
KDM4E B2RXH2 2/20 0.39
TP53 P04637 1/20 0.39
MAPK1 P28482 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
KDM1A O60341 1/20 0.38
KCNH2 Q12809 1/20 0.38
IRAK4 Q9NWZ3 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1055480 0.85 GPR119 (0.51) PDE4BPDE4APDE4CPDE4D
SCHEMBL1052689 0.81 GPR119 (0.51) PDE4BPDE4APDE4CPDE4D
SCHEMBL7144063 0.74 PDE4B (0.53) BRD4PDE4BPDE4APDE4CPDE4D
SCHEMBL10827884 0.74 ALDH1A1 (0.46) LMNAMEN1KMT2AALDH1A1ATM
SCHEMBL2879359 0.69 GPR119 (0.52) BRD4KCNH2
SCHEMBL1052671 0.68 PDE4B (0.48) PDE4BPDE4APDE4CPDE4DKDM4E
SCHEMBL3840018 0.67 GRIN2B (0.50) GRIN2BKDM4E
SCHEMBL3844800 0.67 HRH3 (0.44) GRIN2B
SCHEMBL3839998 0.67 GPR119 (0.51)
SCHEMBL3841482 0.67 GPR119 (0.51)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1648455-A4 ANAPLASTIC LYMPHOMA KINASE MODULATORS AND METHODS OF USE EXELIXIS INC (US) 2009-03-04 EP disclosed
EP-1648455-A2 ANAPLASTIC LYMPHOMA KINASE MODULATORS AND METHODS OF USE Exelixis, Inc. (US) 2006-04-26 EP disclosed
WO-2005009389-A2 ANAPLASTIC LYMPHOMA KINASE MODULATORS AND METHODS OF USE EXELIXIS, INC. (US) 2005-02-03 WO disclosed